Should you build relationships with VCs before a raise? That’s a hard yes.
This is a hot topic and I’ve heard plenty of arguments with both sides. Here’s my POV.
This is a hot topic and I’ve heard plenty of arguments with both sides. Here’s my POV.
This week on Second Opinion, Christina Farr and Ash Zenooz interview Stephen Buck, CEO/Co-Founder of Courage Health.
More perspectives from experienced operators on the great build vs. buy question for fundamental technology used by digital health cos
Lets compare the s-1s of two interesting digital health companies are going public in 2025
This week on Second Opinion, we're sharing an episode from Peter Lee's Microsoft Research Podcast with guests Dave deBronkart and Christina Farr.
Employers tell me that preventative health is harder than ever
This week on Second Opinion, Christina Farr and Ash Zenooz interview Seraphina Therapeutics CEO Steph Venn-Watson, unpacking why men dominate the longevity space, the cellular secrets of aging, and C15:0’s potential to boost health.
What are the hidden trade offs of fund size. When should founders be able to take money off the table?
In this episode of Second Opinion, hosts Christina Farr, Ash Zenooz, and Luba Greenwood discuss the latest trends in healthcare, including conferences, the economic impact on health tech and biotech sectors, the potential for AI to reduce administrative burdens, and the dynamics of the IPO market.
The age old question revisited, but with a 2025 spin